(Q48720555)

14 February 2018

title

Laboratory tests and imaging studies in patients with cutaneous malignant melanomas: a survey of experienced physicians (English)

1 reference

14 February 2018

author name string

Provost N

1

1 reference

14 February 2018

Marghoob AA

2

1 reference

14 February 2018

Kopf AW

3

1 reference

14 February 2018

DeDavid M

4

1 reference

14 February 2018

Wasti Q

5

1 reference

14 February 2018

Bart RS

6

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 May 1997

1 reference

14 February 2018

Journal of the American Academy of Dermatology

published in

1 reference

14 February 2018

volume

36

1 reference

14 February 2018

issue

5 Pt 1

1 reference

14 February 2018

page(s)

711-720

1 reference

14 February 2018

cites work

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Metastatic pattern of malignant melanoma. A study of 216 autopsy cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Frequency and duration of patient follow-up after treatment of a primary malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Follow-up recommendations for patients with stage I malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Risk of developing multiple primary cutaneous melanomas in patients with the classic atypical-mole syndrome: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Melanoma recurrence surveillance. Patient or physician based?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Role of computed tomography in the staging of patients with local-regional metastases of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Role of computed tomography in the staging of primary melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Cost-effectiveness of surveillance of stage I melanoma. A retrospective appraisal based on a 10-year experience in a dermatology department in France

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

1 reference

7 January 2021

LDH in the follow-up of stage I malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

1 reference

7 January 2021

Evaluation of staging workup in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Stage I-II melanoma: the value of metastatic work-up

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Predictive value of staging investigations in patients with clinical stage I malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Metastatic disease in patients with newly diagnosed malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Hazard-rate analysis in state I malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Sonographic detection and fine-needle aspiration biopsy of nonpalpable recurrent or metastatic melanoma in subcutaneous tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Prognosis for recurrent stage I malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

[Position and recommendations of the Malignant Melanoma Committee of the German Society of Dermatology on diagnosis, treatment and after-care of malignant melanoma of the skin. Status 1993/94]

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Consensus on the management of melanoma of the skin in The Netherlands. Dutch Melanoma Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Diagnosis and Treatment of Early Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Anti-Melanoma Monoclonal Antibody 225.28S Immunoscintigraphy in Metastatic Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Clinical significance of serum S100 in metastatic malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Detection and quantitation of melanoma cells in the circulation of patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

A radiolabelled iodobenzamide for malignant melanoma staging

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2980323-4

7 January 2021

10.1016/S0190-9622(97)80323-4

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018